A new method for diagnosing small cell lung cancer

Do you know about the new method for diagnosing small cell lung cancer? Most people are not very clear about the diagnosis method of this disease. In fact, when you feel unwell, you should check and treat it in time. If you are sure that it is this disease, you should seize the time to treat it. So, let's learn about the new method for diagnosing small cell lung cancer!

Small cell lung cancer is a highly malignant type of lung cancer, with clinical characteristics of short tumor cell doubling time, rapid progression, and often accompanied by endocrine abnormalities or carcinoid syndrome. Clinically, most patients with small cell lung cancer are already in the advanced stage when diagnosed.

Diagnosis of small cell lung cancer:

1. Chest X-ray and radiography can reveal various circular shadows, pneumonia, atelectasis, pleural effusion, etc. Chest X-ray, CT and MRI examinations can help us understand the relationship between the size of the tumor and the lung lobe, segment and bronchi. Bronchial iodized oil contrast can be performed if necessary.

2. Repeated examination of sputum for cancer cells may yield positive results, which are of diagnostic value.

3. Bronchoscopy can directly observe the lesions, and can also take biopsy samples for pathological examination and bronchial secretion smears to check for cancer cells.

4. If the lung puncture is accurately positioned, a smear examination of the puncture material can generally obtain a positive result, which is of diagnostic value.

5. Superficial lymph node puncture or biopsy: When lung cancer has not yet been confirmed or is accompanied by widening of the upper mediastinum, puncture and aspiration of cells or biopsy of palpable lymph nodes on the neck and clavicle, suspicious subcutaneous masses, and suspected cancerous lymph nodes in other parts can be performed to obtain a pathological histological diagnosis.

The medical community has not been able to reach a definite conclusion about the survival period of patients with small cell lung cancer. First of all, small cell lung cancer itself is also a systematic concept. No completely identical cases have ever appeared, so horizontal analogies cannot be made. Secondly, the patient's own condition of small cell lung cancer is the decisive factor in its survival period. The individual differences of patients determine that the survival period of small cell lung cancer is not the same. The improvement of the patient's physical function is an important factor in determining the survival period of late-stage small cell lung cancer. The patient's excellent physical function and strong immune system are enough to resist the expansion or continuous metastasis of the tumor. Finally, the progress of the treatment of small cell lung cancer is also an important factor in determining the patient's survival period. The fundamental treatment actually depends on the patient's own immune ability. Patients with strong immune ability can better tolerate the treatment of various chemical agents. Therefore, the key to the treatment of patients with small cell lung cancer lies in how to enhance the body's immunity.